- Home
- ENSC vs AUUD Comparison
ENSC vs AUUD Comparison
Compare ENSC & AUUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- AUUD
- Stock Information
- Founded
- ENSC 2003
- AUUD 2012
- Country
- ENSC United States
- AUUD United States
- Employees
- ENSC N/A
- AUUD N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- AUUD Computer Software: Prepackaged Software
- Sector
- ENSC Health Care
- AUUD Technology
- Exchange
- ENSC Nasdaq
- AUUD Nasdaq
- Market Cap
- ENSC 2.9M
- AUUD 2.9M
- IPO Year
- ENSC N/A
- AUUD 2021
- Fundamental
- Price
- ENSC $3.29
- AUUD $3.37
- Analyst Decision
- ENSC
- AUUD
- Analyst Count
- ENSC 0
- AUUD 0
- Target Price
- ENSC N/A
- AUUD N/A
- AVG Volume (30 Days)
- ENSC 4.9M
- AUUD 215.8K
- Earning Date
- ENSC 05-12-2025
- AUUD 05-13-2025
- Dividend Yield
- ENSC N/A
- AUUD N/A
- EPS Growth
- ENSC N/A
- AUUD N/A
- EPS
- ENSC N/A
- AUUD N/A
- Revenue
- ENSC $5,210,031.00
- AUUD N/A
- Revenue This Year
- ENSC N/A
- AUUD N/A
- Revenue Next Year
- ENSC N/A
- AUUD N/A
- P/E Ratio
- ENSC N/A
- AUUD N/A
- Revenue Growth
- ENSC 133.58
- AUUD N/A
- 52 Week Low
- ENSC $1.62
- AUUD $2.88
- 52 Week High
- ENSC $14.67
- AUUD $33.32
- Technical
- Relative Strength Index (RSI)
- ENSC 55.92
- AUUD 40.10
- Support Level
- ENSC $3.02
- AUUD $2.88
- Resistance Level
- ENSC $4.85
- AUUD $6.49
- Average True Range (ATR)
- ENSC 0.40
- AUUD 0.86
- MACD
- ENSC 0.27
- AUUD -0.03
- Stochastic Oscillator
- ENSC 51.70
- AUUD 13.57
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.